CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $3.24M invested in Celyad Oncology SA American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
8
Holding in Top 10
1
Calls
–
Puts
–
Top Sellers
| 1 | -$16K | |
| 2 | -$6.06K | |
| 3 | -$2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.43K |
| 5 |
Morgan Stanley
New York
|
-$296 |